The production of ventilators can be established in Kazakhstan
Turkish investors can arrange the production of mechanical ventilation devices in Kazakhstan. Within the framework of interstate negotiations with the active participation of the Embassy of the Republic of Kazakhstan in the Republic of Turkey, the possibility of mastering the production of the Biyovent ventilator from Biosys is being considered.
Today, “NC“ Kazakhstan Engineering ”JSC, with the assistance of “NC” “KAZAKH INVEST” JSC”, is exploring the possibility of organizing the production of medical devices at the“Kazakhstan Aselsan Engineering” joint Kazakhstan-Turkish LLP
“Against the background of an increase in the incidence rate and the predicted scenario for COVID-19, the health authorities plan to additionally acquire 3-4 thousand mechanical ventilation. The serial production of these devices was launched in April 2020 in Turkey. To date, Biyovent ventilation has already been provided for testing in the city infectious center of Nur Sultan. Based on the results of the research, a decision will be made on the localization of production, ”said Amir Akhmetov, project manager of the Project Department No. 2 of “ NC “KAZAKH INVEST” JSC.
According to experts, Biosys is a developer and manufacturer of biomedical equipment in Turkey. Mechanical ventilation was developed and manufactured using exclusively domestic production capabilities of Turkish enterprises. This device is the result of 5 years of research and development with the assistance of the Ministry of Science, Industry, and Technology of the Republic of Turkey and the Bilkent Technopark.
Biyovent ventilator has an intelligent security system and a user-friendly interface. The device is compatible with a different group of patients (neonatal, pediatric, adult), uses advanced adaptive control algorithms. The device was finalized in a short time by a consortium of ASELSAN, Bilkent, Biosys, Arçelik Turkish companies with the participation of about 100 engineers.